Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002539802 | SCV003444590 | uncertain significance | not provided | 2022-06-29 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 222 of the XK protein (p.Arg222Gly). This missense change has been observed in individual(s) with McLeod syndrome (PMID: 11961232, 17302777). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg222 amino acid residue in XK. Other variant(s) that disrupt this residue have been observed in individuals with XK-related conditions (PMID: 11961232, 17302777, 30800707), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this missense change affects XK function (PMID: 11961232). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). ClinVar contains an entry for this variant (Variation ID: 1300237). |
Gene |
RCV001731242 | SCV001981682 | not provided | McLeod neuroacanthocytosis syndrome | no assertion provided | literature only | This reported XK missense variant predicted to disrupt either structure or function |